Register to leave comments

  • News bot Jan. 29, 2026, 6:32 p.m.

    📋 Amphastar (AMPH) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 17:15:07

    Event Type: Clinical Trial Update

    Event Details:

    Amphastar (AMPH) Announces Clinical Trial Update Amphastar (AMPH) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: potential, well
    • Diseases/Conditions: a differentiated safety profile
    • Collaboration: Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for

    🔬 Clinical Development Pipeline (Amphastar):

    Product Type Development Stage Therapeutic Area Source
    Placebo-HFA DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Albuterol Sulfate (Provenetil-HFA) DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    albuterol (Armstrong Albuterol HFA) DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    HFA placebo DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    albuterol HFA (Proventil HFA) DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    albuterol HFA (Armstrong's) DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Albuterol Sulfate Inhalation Aerosol DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Armstrong Albuterol Sulfate Inhalation Aerosol DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Arm C-Epinephrine Inhalation Aerosol CFC DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    epinephrine inhalation aerosol DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Epinephrine HFA-MDI (E004) DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Arm C: Primatene Mist (epinephrine inhalation aerosol, USP) DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Arm T2: Primatene Mist HFA DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Arm T1: Primatene Mist HFA DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    albuterol inhalation aerosol DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    albuterol inhalation powder DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    E004 (Epinephrine Inhalation Aerosol) HFA-MDI DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Epinephrine Inhalation Aerosol, HFA DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    Proventil-HFA DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Placebo DPI DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    A006 DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Proventil® MDI DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    A006 DPI DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Saline DRUG Phase PHASE2 Allergic Skin Reaction ClinicalTrials.gov
    Histamine DRUG Phase PHASE2 Allergic Skin Reaction ClinicalTrials.gov
    Hyaluronidase DRUG Phase PHASE2 Allergic Skin Reaction ClinicalTrials.gov
    E004 (epinephrine inhalation aerosol), 160 mcg DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    epinephrine inhalation aerosol, CFC propelled DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    E004 (epinephrine inhalation aerosol), 220 mcg DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    E004 (epinephrine inhalation aerosol), 125 mcg DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    E004 Placebo DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    E004 (epinephrine inhalation aerosol), 90 mcg/actuation DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    Albuterol MDI 90 mcg/inh DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Albuterol DPI 90 mcg/inh DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Albuterol DPI 25 mcg/inh DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Epinephrine inhalation DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    Primatene Mist DRUG Phase PHASE3 Asthma ClinicalTrials.gov
    NovoLog DRUG Phase PHASE2 Pharmacokinetics ClinicalTrials.gov
    I004 DRUG Phase PHASE2 Pharmacokinetics ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Amphastar
    • Ticker Symbol: AMPH